1	La	el	DA0FS0	-	-	0-2	110(0)_ANS_clinical_caseMIR	SENT1	-	-
2	evolución	evolución	NCFS000	-	-	3-12	110(0)_ANS_clinical_caseMIR	SENT1	-	-
3	es	ser	VSIP3S0	-	-	13-15	110(0)_ANS_clinical_caseMIR	SENT1	-	-
4	normal	normal	AQ0CS0	C0205307	calificador	16-22	110(0)_ANS_clinical_caseMIR	SENT1	-	-
5	,	,	Fc	-	-	22-23	110(0)_ANS_clinical_caseMIR	SENT1	-	-
6	debe	deber	VMIP3S0	-	-	24-28	110(0)_ANS_clinical_caseMIR	SENT1	-	-
7	mantener	mantener	VMN0000	-	-	29-37	110(0)_ANS_clinical_caseMIR	SENT1	-	-
8	se	se	PP3CN000	-	-	37-39	110(0)_ANS_clinical_caseMIR	SENT1	-	-
9	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	40-51	110(0)_ANS_clinical_caseMIR	SENT1	-	-
10	hasta	hasta	SPS00	-	-	52-57	110(0)_ANS_clinical_caseMIR	SENT1	-	-
11	completar	completar	VMN0000	-	-	58-67	110(0)_ANS_clinical_caseMIR	SENT1	-	-
12	los	el	DA0MP0	-	-	68-71	110(0)_ANS_clinical_caseMIR	SENT1	-	-
13	10	10	Z	-	-	72-74	110(0)_ANS_clinical_caseMIR	SENT1	-	-
14	días	d	NCMP000	-	-	75-79	110(0)_ANS_clinical_caseMIR	SENT1	-	-
15	.	.	Fp	-	-	80-81	110(0)_ANS_clinical_caseMIR	SENT1	-	-

